MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Imaging the Nigrostriatal Pathway in Patients with Idiopathic Normal Pressure Hydrocephalus and Parkinsonism

    G. Palermo, A. Francesconi, G. Bellini, R. Morganti, G. Migaleddu, D. Di Carlo, P. Perrini, N. Benedetto, C. Pacchetti, D. Volterrani, M. Cosottini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the nigrostriatal pathway in iNPH patients with clinical parkinsonism, employing dopaminergic transporter (DAT) and nigrosome imaging. Background: Patients with idiopathic Normal Pressure…
  • 2024 International Congress

    Device-aided Recording of Gait Parameters and Motor Fluctuations in Patients with advanced Parkinson’s disease in the Home Environment

    C. Schrader (Hannover, Germany)

    Objective: To objectively assess mobility and gait parameters in the ON and OFF state in patients with advanced Parkinson's disease (PD) under everyday conditions using…
  • 2024 International Congress

    The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases

    J. Maple-Grødem, V. Frantzen, J. Lange, E. Fiske, E. Bjordal, V. Forsaa, ø. Kallevåg, J. Berge, A. Jimenez, P. Førland, D. Aarsland, G. Alves (Stavanger, Norway)

    Objective: The Pro-LBD cohort study is a prospective, long-term, clinic-biological cohort study of participants who are stratified by their risk of developing a Lewy body…
  • 2024 International Congress

    Patient and Caregiver Experiences with Tardive Dyskinesia: Emotions, Challenges, and Unmet Needs in the Patient Journey

    A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)

    Objective: To describe the emotional journey from symptom onset to current state and identify challenges and unmet needs of participants living with tardive dyskinesia (TD)…
  • 2024 International Congress

    Evaluation of Neurotransmitter and Co-transmitter Expression in the Aging Human Locus Coeruleus: Relevance to Neurodegenerative Disorders.

    A. Bhattacharya, A. Mahadevan, R. Manjithaya, Y. Tc, P. Alladi (Bengaluru, India)

    Objective: To analyze the age-associated changes in the neurotransmitter/co-transmitter expression and morphometric profiles of human locus coeruleus (LC) neurons using autopsied human tissues. Background: LC…
  • 2024 International Congress

    Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease

    N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the decline in functionality according to WHODAS-2.0 from early to intermediate stages of PD. Background: Parkinson's disease (PD) is an incurable and…
  • 2024 International Congress

    Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease

    A. Gallagher, H. Elliott, J. Inocentes, C. O'Keeffe, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)

    Objective: The objective of our study is to determine whether differences in oculomotor function and blink rate correlate to the off-and on- medication state in a cohort of…
  • 2024 International Congress

    Association between Hyperglycemic Crisis Severity and Movement Disorders in Hispanic Patients with De Novo Hyperglycemia: A Cross-Sectional Study

    D. Japón-Cueva, C. Rodriguez-Alarcon, A. Carofilis-Cornejo, L. Viñan-Paucar, M. Cueva-Espinoza, A. Benavidez-Lopez, P. Gruezo-Realpe, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Exploring the correlation between hyperglycemic crisis (HC) severity and movement disorders (MD) in Hispanic patients with De Novo Hyperglycemia (DNH). Background: Limited research exists…
  • 2024 International Congress

    Real-life experience of switching from D-penicillamine to trientine tetrahydrochloride – a nationwide registry study

    A. Poujois, MA. Obadia, N. Oussedik-Djebrani, E. Couchonnal-Bedoya, D. Debray (PARIS, France)

    Objective: Our aim was to assess the efficacy and safety of trientine tetrahydrochloride (TETA4HCL) in a cohort of neurological Wilson's disease (WD) patients transitioned from…
  • 2024 International Congress

    Hemochromatosis and Movement Disorders

    P J. Garcia Ruiz, C. Garcia Campos, C. Feliz, J. Del Val, J. Montoya (Torrelodones, Spain)

    Objective: To describe a  series (clinical  and imaging)  of movement disorders occurring in  patients with hemochromatosis Background: Hemochromatosis is a frequent disease, characterized by deposits…
  • « Previous Page
  • 1
  • …
  • 528
  • 529
  • 530
  • 531
  • 532
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley